HLB Pharmaceutical Correlations
| 047920 Stock | KRW 22,500 400.00 1.75% |
The current 90-days correlation between HLB Pharmaceutical and Kolon Life Science is -0.01 (i.e., Good diversification). The correlation of HLB Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
HLB Pharmaceutical Correlation With Market
Good diversification
The correlation between HLB Pharmaceutical Co and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding HLB Pharmaceutical Co and DJI in the same portfolio, assuming nothing else is changed.
HLB |
The ability to find closely correlated positions to HLB Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HLB Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HLB Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HLB Pharmaceutical Co to buy it.
Moving together with HLB Stock
Moving against HLB Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between HLB Stock performing well and HLB Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HLB Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 102940 | 1.42 | (0.23) | 0.00 | 1.39 | 0.00 | 3.11 | 8.97 | |||
| 216080 | 2.24 | 0.23 | 0.07 | 0.58 | 1.96 | 5.98 | 17.39 | |||
| 074430 | 1.41 | (0.34) | 0.00 | (4.43) | 0.00 | 2.76 | 13.89 | |||
| 023910 | 0.66 | (0.02) | (0.12) | (0.09) | 0.85 | 1.37 | 4.95 | |||
| 047920 | 2.70 | (0.12) | 0.00 | 0.80 | 0.00 | 6.03 | 33.52 | |||
| 330350 | 1.46 | (0.33) | 0.00 | 5.83 | 0.00 | 3.10 | 9.83 | |||
| 065660 | 1.57 | 0.02 | (0.05) | (0.40) | 2.14 | 3.93 | 11.37 | |||
| 106190 | 1.95 | (0.16) | 0.00 | (1.22) | 0.00 | 4.35 | 12.32 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in HLB Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
HLB Pharmaceutical Corporate Management
Elected by the shareholders, the HLB Pharmaceutical's board of directors comprises two types of representatives: HLB Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HLB. The board's role is to monitor HLB Pharmaceutical's management team and ensure that shareholders' interests are well served. HLB Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HLB Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JongBin Kim | Managing Director | Profile | |
| Dong Lee | Assistant Managing Director | Profile | |
| Jeong Yoo | Assistant Managing Director | Profile | |
| Jae Noh | Internal Auditor | Profile | |
| DongYeop Lee | Managing Director | Profile | |
| Jeong Yoon | Director | Profile |